January 31, 2025 - 19:35

The White House has plunged much of the government’s health-care apparatus into disarray, raising concerns among advocates and experts alike. This approach, characterized by rapid policy changes and a lack of cohesive strategy, has left many questioning the future of health care in the country.
The administration's decisions have led to significant disruptions in programs designed to provide essential services to millions of Americans. As funding cuts and regulatory rollbacks take effect, vulnerable populations are at risk of losing access to necessary medical care. Health care providers are also feeling the strain, grappling with uncertainty in funding and policy frameworks that affect their ability to deliver services effectively.
Critics argue that this slash-and-burn tactic could exacerbate existing health disparities and lead to a rise in preventable illnesses. As the administration continues to pursue its agenda, the long-term implications for the health care system remain unclear, prompting urgent calls for a more stable and inclusive approach to health care policy.
July 23, 2026 - 15:06
Good riddance to bundled ‘global’ maternal care billingThe American College of Obstetricians and Gynecologists is welcoming a major shift in how pregnancy and childbirth are billed. For years, the system relied on a single, bundled `global` fee that...
July 22, 2026 - 21:50
West Nile virus found in two mosquito traps in DeKalb County, health officials sayHealth authorities in DeKalb County have confirmed that mosquitoes collected from two separate traps have tested positive for the West Nile virus. The positive samples were identified during...
July 22, 2026 - 08:37
Bradford A&E services downgraded by health watchdogA health watchdog has downgraded the accident and emergency services at Bradford Royal Infirmary following an inspection that uncovered significant concerns. The Care Quality Commission (CQC) found...
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...